A Single-center Experience of CardioMEMS in Patients With Left Ventricular Assist Devices

医学 心力衰竭 回顾性队列研究 人口 队列 内科学 单中心 心室辅助装置 心脏病学 病历 环境卫生
作者
Kathleen Morris,Affan Haleem,Rafael Garcia‐Cortes,Amit Patel,Jordan Thomas,Sangita Sudharshan,Sunit‐Preet Chaudhry,Ashwin Ravichandran
出处
期刊:Asaio Journal [Lippincott Williams & Wilkins]
卷期号:68 (7): e116-e117
标识
DOI:10.1097/mat.0000000000001568
摘要

Brief Report Cardiomems (CMEMS) have been demonstrated to reduce hospitalizations in symptomatic HF. The purpose of our study is to describe our experience of CMEMS in our 27 left ventricular assist device (LVAD) patients. We found that there was a 56% reduction in HF hospitalizations at 6 mo and up to 29% reduction in HF hospitalizations at 12 mo pre- and post-CMEMS placement. Further investigation is warranted in a large cohort with a particular focus on the effects on the hemocompatibility LVAD complications. Brief Communication Left ventricular assist devices are the standard of care for the treatment of patients with advanced heart failure (HF). Despite this therapy, nearly 20% of patients have residual HF symptoms resulting in increased morbidity, mortality, and decrease in quality of life. The CardioMEMS (CMEMS) pulmonary artery (PA) sensor allows for frequent collection of hemodynamic information and has been proven to reduce HF hospitalizations in chronic HF patients.1,2 Data regarding efficacy in the LVAD population is limited to small case series. We describe our single-center experience using the CMEMS system in this patient population. We performed a retrospective study of 27 LVAD patients who underwent placement of the CMEMS device between August 2018 and January 2020 at Ascension St. Vincent Data was extracted through the electronic medical record systems. Patients were selected based on high-risk features such as frequent hospitalizations pre CMEMS implant. Baseline characteristics and outcome analysis including HF hospitalizations occurring in the 1 y pre- and 6 mo and 1 y post-CMEMS implantation in these patients were collected. All implants were performed after LVAD placement without interruption of anticoagulation, with the majority (89%) performed by the right internal jugular approach without interruption of anticoagulation. Technique was similar among implanting cardiologists including gaining access with an 11 French Terumo sheath and either a 260 cm Cardiomems guidewire or 300 cm Steelcore to selectively engage the appropriately sized vessel in the left PA. A hand injection of a mixture of ~10 mL of iodinated contrast and normal saline was then used under fluoroscopy for vessel identification, followed by re-engagement of the vessel with the wire and the implant then performed as described by the IFU. At the time of implant, goal PADP was set for the patient, and subsequent PA pressure data was then used to adjust diuretics, guideline-directed medical therapy, or speed adjustments in a stepwise fashion at the discretion of the patient’s primary cardiologist or CMEMS implanter. Baseline demographics were collected and included a mean age of 56 with 71% male with all with end-stage HF with LVAD support with HM3 (55%), HM2 (9%), and HVAD (36%) with 43% as a bridge to transplant. There was no significant difference in pulmonary vascular resistance between LVAD recipients with and without CMEMS. As seen in Figure 1, there was a 58% reduction in HF hospitalizations at 6 mo and up to 29% reduction in HF hospitalizations at 12 mo pre- and post-CMEMS placement. When HF hospitalization was further delineated by primary or secondary diagnosis, this reduction was even more marked (64% at 6 mo and 47% at 1 y, respectively). The procedure was remarkably safe in this anticoagulated, continuous flow population, with only 3% of patients developing scant hemoptysis that resolved without any intervention.Figure 1.: Primary endpoint of HF hospitalizations.Major limitations to these observations exist including the limited number of patients examined in a retrospective and single-center nature. Additionally, patients were selected for PA sensor implant at the discretion of their primary cardiologist and influenced by factors such as adherence to treatment recommendations and monitoring, distance traveled to LVAD center and other clinical characteristics that may introduce significant bias. Hospitalizations remain a large burden for LVAD patients, with some reports of >70% of patients needing hospitalization within the first-year postimplant.3,4 Elevated filling pressures may not only lead to HF hospitalizations but also lead to hemocompatibility related adverse events that may further complications associated with LVADs contributing to morbidity5,6 further hospitalizations. If the signal of reduced hospitalization for HF as both a primary and secondary diagnosis can be replicated in a larger population, PA sensor monitoring may present a safe and unique opportunity to decrease morbidity in a population that often struggles with the adverse events associated with LVAD therapy. Further investigation is required to examine the generalizability of these findings and whether other adverse events such as right ventricular failure, hemocompatibility related adverse events, or infection are truly impacted by more intensive hemodynamics monitoring.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhu发布了新的文献求助10
1秒前
1秒前
独特听芹完成签到,获得积分10
3秒前
zz完成签到,获得积分10
3秒前
4秒前
晚风完成签到,获得积分10
5秒前
jwj发布了新的文献求助10
6秒前
6秒前
白熊完成签到 ,获得积分10
6秒前
7秒前
李健应助北齐冲浪的鱼采纳,获得10
8秒前
8秒前
王一鸣发布了新的文献求助10
9秒前
ikutovaya完成签到,获得积分10
9秒前
9秒前
奋斗的妙松完成签到,获得积分10
10秒前
老实莫言完成签到,获得积分10
10秒前
11秒前
量子星尘发布了新的文献求助150
11秒前
wop111应助morph采纳,获得20
11秒前
追寻的冬寒完成签到 ,获得积分10
12秒前
13秒前
吼吼吼吼发布了新的文献求助10
13秒前
善学以致用应助生动念烟采纳,获得10
13秒前
由天与发布了新的文献求助10
14秒前
wsy发布了新的文献求助10
15秒前
17秒前
19秒前
19秒前
20秒前
lllllll完成签到,获得积分10
21秒前
21秒前
王一鸣完成签到,获得积分10
22秒前
量子星尘发布了新的文献求助10
24秒前
心灵尔安完成签到 ,获得积分10
25秒前
你终硕发布了新的文献求助10
25秒前
科研通AI6应助满意的又蓝采纳,获得10
25秒前
jwj完成签到,获得积分10
26秒前
27秒前
大个应助gc529采纳,获得10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
NMR in Plants and Soils: New Developments in Time-domain NMR and Imaging 600
Electrochemistry: Volume 17 600
Physical Chemistry: How Chemistry Works 500
SOLUTIONS Adhesive restoration techniques restorative and integrated surgical procedures 500
Energy-Size Reduction Relationships In Comminution 500
Principles Of Comminution, I-Size Distribution And Surface Calculations 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4950711
求助须知:如何正确求助?哪些是违规求助? 4213460
关于积分的说明 13104286
捐赠科研通 3995337
什么是DOI,文献DOI怎么找? 2186837
邀请新用户注册赠送积分活动 1202090
关于科研通互助平台的介绍 1115359